Authorities warn of "severe" flu season, compared to last year

Xofluza was approved by the FDA for treatment of acute uncomplicated influenza in patients 12 years of age and older.

Xofluza was approved by the FDA for treatment of acute uncomplicated influenza in patients 12 years of age and older. Source: Getty Images

In an average year, three to four thousand people will die from flu-related complications in Australia but authorities say this year's flu season has already seen some signs that could see the number increase.



Share

Follow SBS Nepali

Download our apps

Listen to our podcasts

Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS

Nepali News

Watch it onDemand

Watch now